Уровень оригинальных лекарственных средств отечественного производства на российском рынке остается низким. Речь идет о единицах наименований. Производители неохотно идут по пути разработки, поскольку не имеют гарантии окупаемости затрат на фармацевтические исследования и регистрацию. Этому способствует достаточно короткий срок действия патента, половину которого занимают регистрационные и исследовательские процедуры. Об этом шла речь 23 июня на заседании круглого стола комитета по охране здоровья Госдумы «Вопросы организации полного цикла производства лекарственных препаратов на территории Российской Федерации», который прошел на площадке Законодательного собрания Калининградской области.
Срок действия патента — 25 лет. В среднем путь от разработки новой молекулы до вывода готового продукта в клиническую практику занимает от 10 до 15 лет. При этом первые годы препарат не слишком известен потребителю и не окупает вложенные в него инвестиции. То есть на возврат вложений остается порядка 5 лет, что создает риски для бизнеса и тормозит разработку новых действующих веществ непосредственно в России.
Действенной мерой поддержки производителей оригинальных препаратов могут стать налоговые льготы.
«Первые 10 лет после регистрации новой молекулы — самый сложный период для нового лекарственного продукта. На этом цикле было бы уместно поддержать предприятия. Действенной мерой может стать обнуление налога на прибыль по инновационному отечественному лекарству с оригинальным международным непатентованным наименованием. Датой отсчета по такому продукту для нулевого налога на прибыль предлагаем брать его дату регистрацию в реестре ЕАЭС», — озвучил в своём докладе Антон Бойко, директор калининградского ООО «Инфамед К» (производит оригинальные препараты «Окомистин», «Мирамистин»).
С тем, что налоговые льготы являются оптимальной мерой поддержки для такой отрасли, как отечественное производство препаратов, согласен и депутат Госдумы от Калининградской области Андрей Горохов.
«Фарме требуется помощь государства, лучше всего это работает в форме отсрочки платежей по налогам и компенсации затрат на инвестиции из налогов будущих периодов», — прокомментировал предложение член комитета по охране здоровья.
Председатель комитета Бадма Башанкаев, отвечая на вопрос RUGRAD о жизнеспособности такой меры поддержки для фармбизнеса в России в целом или в Калининградской области как в модельном регионе, назвал предложение «имеющим здравое зерно».
«Мы обсудим его с параллельными комитетатами. Почему нет? Это поддержка наших производителей и безопасности, и задача государства — это поддержать», — заключил Башанкаев.
{"ID":"1338048","~ID":"1338048","TAGS":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","~TAGS":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","NAME":"Калининградская фарма попросила у Госдумы нулевую ставку по налогу на прибыль на новые разработки","~NAME":"Калининградская фарма попросила у Госдумы нулевую ставку по налогу на прибыль на новые разработки","IBLOCK_ID":"54","~IBLOCK_ID":"54","IBLOCK_SECTION_ID":"829","~IBLOCK_SECTION_ID":"829","DETAIL_TEXT":"\u003Cp\u003E\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t Уровень оригинальных лекарственных средств отечественного производства на российском рынке остается низким. Речь идет о единицах наименований. Производители неохотно идут по пути разработки, поскольку не имеют гарантии окупаемости затрат на фармацевтические исследования и регистрацию. Этому способствует достаточно короткий срок действия патента, половину которого занимают регистрационные и исследовательские процедуры. Об этом шла речь 23 июня на заседании круглого стола комитета по охране здоровья Госдумы «Вопросы организации полного цикла производства лекарственных препаратов на территории Российской Федерации», который прошел на площадке Законодательного собрания Калининградской области.\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t Срок действия патента — 25 лет. В среднем путь от разработки новой молекулы до вывода готового продукта в клиническую практику занимает от 10 до 15 лет. При этом первые годы препарат не слишком известен потребителю и не окупает вложенные в него инвестиции. То есть на возврат вложений остается порядка 5 лет, что создает риски для бизнеса и тормозит разработку новых действующих веществ непосредственно в России.\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t Действенной мерой поддержки производителей оригинальных препаратов могут стать налоговые льготы. \u003Cimg width=\u0022180\u0022 src=\u0022\/upload\/medialibrary\/530\/644vjny98yps5zkz21v23wykuc9z6es6.png\u0022 height=\u0022180\u0022 align=\u0022left\u0022\u003E«Первые 10 лет после регистрации новой молекулы — самый сложный период для нового лекарственного продукта. На этом цикле было бы уместно поддержать предприятия. Действенной мерой может стать обнуление налога на прибыль по инновационному отечественному лекарству с оригинальным международным непатентованным наименованием. Датой отсчета по такому продукту для нулевого налога на прибыль предлагаем брать его дату регистрацию в реестре ЕАЭС», — озвучил в своём докладе \u003Cb\u003EАнтон Бойко\u003C\/b\u003E, директор калининградского ООО «Инфамед К» (производит оригинальные препараты «Окомистин», «Мирамистин»).\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n \u003Cimg width=\u0022180\u0022 src=\u0022\/upload\/medialibrary\/1a4\/1a4e431c4a69afed86f8774b14d61597.jpg\u0022 height=\u0022177\u0022 align=\u0022right\u0022\u003EС тем, что налоговые льготы являются оптимальной мерой поддержки для такой отрасли, как отечественное производство препаратов, согласен и депутат Госдумы от Калининградской области \u003Cb\u003EАндрей Горохов\u003C\/b\u003E.\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t «Фарме требуется помощь государства, лучше всего это работает в форме отсрочки платежей по налогам и компенсации затрат на инвестиции из налогов будущих периодов», — прокомментировал предложение член комитета по охране здоровья.\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n \u003Cimg width=\u0022180\u0022 src=\u0022\/upload\/medialibrary\/36d\/706v1lbwbo6wvwvpdbb2btaom5l8skrj.png\u0022 height=\u0022180\u0022 align=\u0022left\u0022\u003EПредседатель комитета \u003Cb\u003EБадма Башанкаев\u003C\/b\u003E, отвечая на вопрос RUGRAD о жизнеспособности такой меры поддержки для фармбизнеса в России в целом или в Калининградской области как в модельном регионе, назвал предложение «имеющим здравое зерно».\u0026nbsp;\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t «Мы обсудим его с параллельными комитетатами. Почему нет? Это поддержка наших производителей и безопасности, и задача государства — это поддержать», — заключил Башанкаев.\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\u003C\/p\u003E\r\n \u003Cbr\u003E","~DETAIL_TEXT":"\u003Cp\u003E\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t Уровень оригинальных лекарственных средств отечественного производства на российском рынке остается низким. Речь идет о единицах наименований. Производители неохотно идут по пути разработки, поскольку не имеют гарантии окупаемости затрат на фармацевтические исследования и регистрацию. Этому способствует достаточно короткий срок действия патента, половину которого занимают регистрационные и исследовательские процедуры. Об этом шла речь 23 июня на заседании круглого стола комитета по охране здоровья Госдумы «Вопросы организации полного цикла производства лекарственных препаратов на территории Российской Федерации», который прошел на площадке Законодательного собрания Калининградской области.\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t Срок действия патента — 25 лет. В среднем путь от разработки новой молекулы до вывода готового продукта в клиническую практику занимает от 10 до 15 лет. При этом первые годы препарат не слишком известен потребителю и не окупает вложенные в него инвестиции. То есть на возврат вложений остается порядка 5 лет, что создает риски для бизнеса и тормозит разработку новых действующих веществ непосредственно в России.\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t Действенной мерой поддержки производителей оригинальных препаратов могут стать налоговые льготы. \u003Cimg width=\u0022180\u0022 src=\u0022\/upload\/medialibrary\/530\/644vjny98yps5zkz21v23wykuc9z6es6.png\u0022 height=\u0022180\u0022 align=\u0022left\u0022\u003E«Первые 10 лет после регистрации новой молекулы — самый сложный период для нового лекарственного продукта. На этом цикле было бы уместно поддержать предприятия. Действенной мерой может стать обнуление налога на прибыль по инновационному отечественному лекарству с оригинальным международным непатентованным наименованием. Датой отсчета по такому продукту для нулевого налога на прибыль предлагаем брать его дату регистрацию в реестре ЕАЭС», — озвучил в своём докладе \u003Cb\u003EАнтон Бойко\u003C\/b\u003E, директор калининградского ООО «Инфамед К» (производит оригинальные препараты «Окомистин», «Мирамистин»).\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n \u003Cimg width=\u0022180\u0022 src=\u0022\/upload\/medialibrary\/1a4\/1a4e431c4a69afed86f8774b14d61597.jpg\u0022 height=\u0022177\u0022 align=\u0022right\u0022\u003EС тем, что налоговые льготы являются оптимальной мерой поддержки для такой отрасли, как отечественное производство препаратов, согласен и депутат Госдумы от Калининградской области \u003Cb\u003EАндрей Горохов\u003C\/b\u003E.\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t «Фарме требуется помощь государства, лучше всего это работает в форме отсрочки платежей по налогам и компенсации затрат на инвестиции из налогов будущих периодов», — прокомментировал предложение член комитета по охране здоровья.\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n \u003Cimg width=\u0022180\u0022 src=\u0022\/upload\/medialibrary\/36d\/706v1lbwbo6wvwvpdbb2btaom5l8skrj.png\u0022 height=\u0022180\u0022 align=\u0022left\u0022\u003EПредседатель комитета \u003Cb\u003EБадма Башанкаев\u003C\/b\u003E, отвечая на вопрос RUGRAD о жизнеспособности такой меры поддержки для фармбизнеса в России в целом или в Калининградской области как в модельном регионе, назвал предложение «имеющим здравое зерно».\u0026nbsp;\u0026nbsp;\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\t «Мы обсудим его с параллельными комитетатами. Почему нет? Это поддержка наших производителей и безопасности, и задача государства — это поддержать», — заключил Башанкаев.\r\n\u003C\/p\u003E\r\n\u003Cp\u003E\r\n\u003C\/p\u003E\r\n \u003Cbr\u003E","DETAIL_TEXT_TYPE":"html","~DETAIL_TEXT_TYPE":"html","PREVIEW_TEXT":"В комитете по охране здоровья пообещали «обсудить предложение».","~PREVIEW_TEXT":"В комитете по охране здоровья пообещали «обсудить предложение».","PREVIEW_TEXT_TYPE":"text","~PREVIEW_TEXT_TYPE":"text","DETAIL_PICTURE":{"ID":"3841491","TIMESTAMP_X":"23.06.2023 17:18:14","MODULE_ID":"iblock","HEIGHT":"299","WIDTH":"450","FILE_SIZE":"68556","CONTENT_TYPE":"image\/jpeg","SUBDIR":"iblock\/6a0","FILE_NAME":"abez901k3lcnt2zkdg7dsy2wgelzlos1.jpg","ORIGINAL_NAME":"мирамистин, горохов, инфамед, экобалтик.jpg","DESCRIPTION":"","HANDLER_ID":null,"EXTERNAL_ID":"fcd334ef6a9de3df973478cedad27575","VERSION_ORIGINAL_ID":null,"META":"","SRC":"\/upload\/iblock\/6a0\/abez901k3lcnt2zkdg7dsy2wgelzlos1.jpg"},"~DETAIL_PICTURE":"3841491","ACTIVE_FROM_X":"2023-06-25 15:47:00","~ACTIVE_FROM_X":"2023-06-25 15:47:00","ACTIVE_FROM":"25.06.2023 15:47:00","~ACTIVE_FROM":"25.06.2023 15:47:00","LIST_PAGE_URL":"news.php?ID=54","~LIST_PAGE_URL":"\/news\/","PROPERTY_FOTO_DESC_VALUE":"Фото rugrad","~PROPERTY_FOTO_DESC_VALUE":"Фото rugrad","PROPERTY_FOTO_DESC_VALUE_ID":"1338048:1498","~PROPERTY_FOTO_DESC_VALUE_ID":"1338048:1498","PROPERTY_CLIPART_VALUE":"N","~PROPERTY_CLIPART_VALUE":"N","PROPERTY_CLIPART_VALUE_ID":"1338048:1262","~PROPERTY_CLIPART_VALUE_ID":"1338048:1262","PROPERTY_DOPINFO_VALUE":[{"TEXT":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u003Ca href=\u0022https:\/\/rugrad.online\/news\/1327780\/\u0022\u003EАО «Отисифарм Про\u003C\/a\u003E». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек.","TYPE":"HTML"}],"~PROPERTY_DOPINFO_VALUE":[{"TEXT":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u003Ca href=\u0022https:\/\/rugrad.online\/news\/1327780\/\u0022\u003EАО «Отисифарм Про\u003C\/a\u003E». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек.","TYPE":"HTML"}],"PROPERTY_SOURCE_VALUE":null,"~PROPERTY_SOURCE_VALUE":null,"PROPERTY_SOURCE_VALUE_ID":"1338048:275","~PROPERTY_SOURCE_VALUE_ID":"1338048:275","PROPERTY_IFRM_VALUE":null,"~PROPERTY_IFRM_VALUE":null,"PROPERTY_IFRM_VALUE_ID":"1338048:1731","~PROPERTY_IFRM_VALUE_ID":"1338048:1731","PROPERTY_KEYWORDS_VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","~PROPERTY_KEYWORDS_VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","PROPERTY_KEYWORDS_VALUE_ID":"1338048:274","~PROPERTY_KEYWORDS_VALUE_ID":"1338048:274","PROPERTY_DESCRIPTION_VALUE":null,"~PROPERTY_DESCRIPTION_VALUE":null,"PROPERTY_DESCRIPTION_VALUE_ID":"1338048:273","~PROPERTY_DESCRIPTION_VALUE_ID":"1338048:273","PROPERTY_FOTO_GALLERY_VALUE":null,"~PROPERTY_FOTO_GALLERY_VALUE":null,"PROPERTY_FOTO_GALLERY_VALUE_ID":"1338048:969","~PROPERTY_FOTO_GALLERY_VALUE_ID":"1338048:969","PROPERTY_NOT_COMMENT_VALUE":"0","~PROPERTY_NOT_COMMENT_VALUE":"0","PROPERTY_NOT_COMMENT_VALUE_ID":"1338048:1466","~PROPERTY_NOT_COMMENT_VALUE_ID":"1338048:1466","PROPERTY_PR_VALUE":"0","~PROPERTY_PR_VALUE":"0","PROPERTY_PR_VALUE_ID":"1338048:1315","~PROPERTY_PR_VALUE_ID":"1338048:1315","PROPERTY_FORUM_TOPIC_ID_VALUE":null,"~PROPERTY_FORUM_TOPIC_ID_VALUE":null,"PROPERTY_FORUM_TOPIC_ID_VALUE_ID":"1338048:282","~PROPERTY_FORUM_TOPIC_ID_VALUE_ID":"1338048:282","PROPERTY_VIDEO_VALUE":[],"~PROPERTY_VIDEO_VALUE":[],"PROPERTY_VIDEO_IMG_VALUE":[],"~PROPERTY_VIDEO_IMG_VALUE":[],"PROPERTY_THEMES_VALUE":["1222","1224","1225"],"~PROPERTY_THEMES_VALUE":["1222","1224","1225"],"PROPERTY_FILES_VALUE":[],"~PROPERTY_FILES_VALUE":[],"PROPERTY_FILES_DESCRIPTION":[],"~PROPERTY_FILES_DESCRIPTION":[],"LANG_DIR":"\/","~LANG_DIR":"\/","IBLOCK_TYPE_ID":"news","~IBLOCK_TYPE_ID":"news","IBLOCK_CODE":"our_news","~IBLOCK_CODE":"our_news","IBLOCK_EXTERNAL_ID":"54","~IBLOCK_EXTERNAL_ID":"54","LID":"ru","~LID":"ru","PROPERTY_DOPINFO_DESCRIPTION":[null],"~PROPERTY_DOPINFO_DESCRIPTION":[null],"PROPERTY_DOPINFO_PROPERTY_VALUE_ID":["1562204"],"~PROPERTY_DOPINFO_PROPERTY_VALUE_ID":["1562204"],"PROPERTY_VIDEO_DESCRIPTION":[],"~PROPERTY_VIDEO_DESCRIPTION":[],"PROPERTY_VIDEO_PROPERTY_VALUE_ID":[],"~PROPERTY_VIDEO_PROPERTY_VALUE_ID":[],"PROPERTY_VIDEO_IMG_DESCRIPTION":[],"~PROPERTY_VIDEO_IMG_DESCRIPTION":[],"PROPERTY_VIDEO_IMG_PROPERTY_VALUE_ID":[],"~PROPERTY_VIDEO_IMG_PROPERTY_VALUE_ID":[],"PROPERTY_THEMES_DESCRIPTION":[null,null,null],"~PROPERTY_THEMES_DESCRIPTION":[null,null,null],"PROPERTY_THEMES_PROPERTY_VALUE_ID":["1086887","1086888","1086889"],"~PROPERTY_THEMES_PROPERTY_VALUE_ID":["1086887","1086888","1086889"],"PROPERTY_FILES_PROPERTY_VALUE_ID":[],"~PROPERTY_FILES_PROPERTY_VALUE_ID":[],"NAV_RESULT":false,"DISPLAY_ACTIVE_FROM":"Калининград: 25.06.2023 15:47","FIELDS":{"ID":"1338048","TAGS":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев"},"PROPERTIES":{"FOTO_DESC":{"ID":"1498","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Подпись под фото","ACTIVE":"Y","SORT":"1","CODE":"FOTO_DESC","DEFAULT_VALUE":"Фото rugrad.eu","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1498","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1498","VALUE":"Фото rugrad","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"Фото rugrad","~DESCRIPTION":"","~NAME":"Подпись под фото","~DEFAULT_VALUE":"Фото rugrad.eu"},"GROUP":{"ID":"1481","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Номер группы новостей (набора)","ACTIVE":"Y","SORT":"3","CODE":"GROUP","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1481","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"Y","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1481","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Номер группы новостей (набора)","~DEFAULT_VALUE":""},"CLIPART":{"ID":"1262","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Фото клипарт","ACTIVE":"Y","SORT":"5","CODE":"CLIPART","DEFAULT_VALUE":"N","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1262","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1262","VALUE":"N","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"N","~DESCRIPTION":"","~NAME":"Фото клипарт","~DEFAULT_VALUE":"N"},"AUTHOR_ID":{"ID":"703","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Автор","ACTIVE":"Y","SORT":"10","CODE":"AUTHOR_ID","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"703","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":"UserID","IS_REQUIRED":"N","USER_TYPE_SETTINGS":null,"HINT":"","PROPERTY_VALUE_ID":"1338048:703","VALUE":27,"DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":27,"~DESCRIPTION":"","~NAME":"Автор","~DEFAULT_VALUE":""},"KOEFF":{"ID":"1447","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Коэфф цены новости","ACTIVE":"Y","SORT":"15","CODE":"KOEFF","DEFAULT_VALUE":"","PROPERTY_TYPE":"L","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1447","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1447","VALUE":"3","DESCRIPTION":null,"VALUE_ENUM":"3","VALUE_XML_ID":"2dc929032e3321fdd4874e8e3a9e0e39","VALUE_SORT":"50","VALUE_ENUM_ID":"659","~VALUE":"3","~DESCRIPTION":null,"~NAME":"Коэфф цены новости","~DEFAULT_VALUE":""},"AD_SHOW":{"ID":"1176","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Показывать в рекламной компании","ACTIVE":"Y","SORT":"50","CODE":"AD_SHOW","DEFAULT_VALUE":"N","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1176","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1176","VALUE":"N","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"N","~DESCRIPTION":"","~NAME":"Показывать в рекламной компании","~DEFAULT_VALUE":"N"},"DESCRIPTION":{"ID":"273","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Описание","ACTIVE":"Y","SORT":"500","CODE":"DESCRIPTION","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"273","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:273","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Описание","~DEFAULT_VALUE":""},"KEYWORDS":{"ID":"274","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Ключевые слова","ACTIVE":"Y","SORT":"500","CODE":"KEYWORDS","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"274","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:274","VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","~DESCRIPTION":"","~NAME":"Ключевые слова","~DEFAULT_VALUE":""},"SOURCE":{"ID":"275","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Источник","ACTIVE":"Y","SORT":"500","CODE":"SOURCE","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"275","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:275","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Источник","~DEFAULT_VALUE":""},"TOP_NEWS":{"ID":"1457","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"ТОП-новость","ACTIVE":"Y","SORT":"500","CODE":"TOP_NEWS","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"3","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1457","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1457","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"ТОП-новость","~DEFAULT_VALUE":""},"ITSVIDEO":{"ID":"1728","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Видео","ACTIVE":"Y","SORT":"500","CODE":"ITSVIDEO","DEFAULT_VALUE":"N","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1728","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1728","VALUE":"N","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"N","~DESCRIPTION":"","~NAME":"Видео","~DEFAULT_VALUE":"N"},"IFRM":{"ID":"1731","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Ифрейм","ACTIVE":"Y","SORT":"500","CODE":"IFRM","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1731","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"\u003Ciframe _ВСТАВКА_ \u003E\u003C\/iframe\u003E","PROPERTY_VALUE_ID":"1338048:1731","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Ифрейм","~DEFAULT_VALUE":""},"ALT_URL":{"ID":"1732","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"URL","ACTIVE":"Y","SORT":"500","CODE":"ALT_URL","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1732","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"Альтернативный URL","PROPERTY_VALUE_ID":"1338048:1732","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"URL","~DEFAULT_VALUE":""},"DOPINFO":{"ID":"1920","TIMESTAMP_X":"2025-10-31 01:20:12","IBLOCK_ID":"54","NAME":"Допинфо","ACTIVE":"Y","SORT":"500","CODE":"DOPINFO","DEFAULT_VALUE":{"TYPE":"HTML","TEXT":""},"PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":null,"FILE_TYPE":"","MULTIPLE_CNT":"3","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":"HTML","IS_REQUIRED":"N","USER_TYPE_SETTINGS":{"height":200},"HINT":"","PROPERTY_VALUE_ID":["1562204"],"VALUE":[{"TEXT":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u0026lt;a href=\u0026quot;https:\/\/rugrad.online\/news\/1327780\/\u0026quot;\u0026gt;АО «Отисифарм Про\u0026lt;\/a\u0026gt;». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек.","TYPE":"HTML"}],"DESCRIPTION":[null],"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":[{"TEXT":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u003Ca href=\u0022https:\/\/rugrad.online\/news\/1327780\/\u0022\u003EАО «Отисифарм Про\u003C\/a\u003E». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек.","TYPE":"HTML"}],"~DESCRIPTION":[null],"~NAME":"Допинфо","~DEFAULT_VALUE":{"TYPE":"HTML","TEXT":""}},"FOTO_GALLERY":{"ID":"969","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Фото галерея","ACTIVE":"Y","SORT":"551","CODE":"FOTO_GALLERY","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"969","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:969","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Фото галерея","~DEFAULT_VALUE":""},"THEMES":{"ID":"278","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Темы","ACTIVE":"Y","SORT":"700","CODE":"THEMES","DEFAULT_VALUE":"","PROPERTY_TYPE":"G","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"278","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"15","TMP_ID":null,"LINK_IBLOCK_ID":"40","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":["1086887","1086888","1086889"],"VALUE":["1222","1224","1225"],"DESCRIPTION":[null,null,null],"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":["1222","1224","1225"],"~DESCRIPTION":[null,null,null],"~NAME":"Темы","~DEFAULT_VALUE":""},"PERSON_IN_NEWS":{"ID":"928","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Персоны в новости","ACTIVE":"Y","SORT":"720","CODE":"PERSON_IN_NEWS","DEFAULT_VALUE":"","PROPERTY_TYPE":"E","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"928","FILE_TYPE":"","MULTIPLE_CNT":"2","TMP_ID":null,"LINK_IBLOCK_ID":"49","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":["1085943"],"VALUE":["624248"],"DESCRIPTION":[""],"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":["624248"],"~DESCRIPTION":[""],"~NAME":"Персоны в новости","~DEFAULT_VALUE":""},"FIRM_IN_NEWS":{"ID":"929","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Фирмы в новости","ACTIVE":"Y","SORT":"740","CODE":"FIRM_IN_NEWS","DEFAULT_VALUE":"","PROPERTY_TYPE":"E","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"929","FILE_TYPE":"","MULTIPLE_CNT":"2","TMP_ID":null,"LINK_IBLOCK_ID":"50","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":false,"VALUE":false,"DESCRIPTION":false,"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":false,"~DESCRIPTION":false,"~NAME":"Фирмы в новости","~DEFAULT_VALUE":""},"NOT_SHOW_MP":{"ID":"1221","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Не показывать на главной странице (0 - Нет, 1 -да)","ACTIVE":"Y","SORT":"745","CODE":"NOT_SHOW_MP","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1221","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1221","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Не показывать на главной странице (0 - Нет, 1 -да)","~DEFAULT_VALUE":"0"},"NOT_SHOW_L":{"ID":"1462","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Не показывать в ленте (0 - Нет, 1 -да)","ACTIVE":"Y","SORT":"746","CODE":"NOT_SHOW_L","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"3","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1462","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1462","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Не показывать в ленте (0 - Нет, 1 -да)","~DEFAULT_VALUE":"0"},"MAILRU_SHOW":{"ID":"1367","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Вывести на Mail.ru (0 - нет, 1 - да)","ACTIVE":"Y","SORT":"768","CODE":"MAILRU_SHOW","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1367","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1367","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Вывести на Mail.ru (0 - нет, 1 - да)","~DEFAULT_VALUE":"0"},"NOT_COMMENT":{"ID":"1466","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Запретить комментарии (0 - нет, 1 - да)","ACTIVE":"Y","SORT":"769","CODE":"NOT_COMMENT","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1466","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1466","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Запретить комментарии (0 - нет, 1 - да)","~DEFAULT_VALUE":"0"},"MAIN_NEWS":{"ID":"1134","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Главная новость (0 - Нет, 100 - Да)","ACTIVE":"Y","SORT":"770","CODE":"MAIN_NEWS","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"5","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1134","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1134","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Главная новость (0 - Нет, 100 - Да)","~DEFAULT_VALUE":"0"},"REGION_NEWS":{"ID":"1448","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Региональная новость(0 - Нет, 1 - Да)","ACTIVE":"Y","SORT":"771","CODE":"REGION_NEWS","DEFAULT_VALUE":"1","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1448","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1448","VALUE":"1","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"1","~DESCRIPTION":"","~NAME":"Региональная новость(0 - Нет, 1 - Да)","~DEFAULT_VALUE":"1"},"HARD_NEWS":{"ID":"1137","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Горячач новость (0 - Нет, 1 - Да, 2 - Фикс.)","ACTIVE":"Y","SORT":"772","CODE":"HARD_NEWS","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1137","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1137","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Горячач новость (0 - Нет, 1 - Да, 2 - Фикс.)","~DEFAULT_VALUE":"0"},"PR":{"ID":"1315","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Рекламная новость (0 - нет, 1 - да, 2 - не эксп., 3 - афиша, 4 - рестораны)","ACTIVE":"Y","SORT":"774","CODE":"PR","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1315","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"Рекламная новость (0 - нет, 1 - да, 2 - не эксп., 3 - афиша, 4 - рестораны)","PROPERTY_VALUE_ID":"1338048:1315","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Рекламная новость (0 - нет, 1 - да, 2 - не эксп., 3 - афиша, 4 - рестораны)","~DEFAULT_VALUE":"0"},"REMOVE_POPULAR":{"ID":"1441","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Убрать из популярных (0 - нет, 1 - да)","ACTIVE":"Y","SORT":"775","CODE":"REMOVE_POPULAR","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"3","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1441","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1441","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Убрать из популярных (0 - нет, 1 - да)","~DEFAULT_VALUE":"0"},"MAIN_NEWS_PHOTO":{"ID":"1135","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Фото главной новости","ACTIVE":"Y","SORT":"776","CODE":"MAIN_NEWS_PHOTO","DEFAULT_VALUE":"","PROPERTY_TYPE":"F","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1135","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1135","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Фото главной новости","~DEFAULT_VALUE":""},"MAIN_NEWS_DESC":{"ID":"1136","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Анонс для главной новости","ACTIVE":"Y","SORT":"780","CODE":"MAIN_NEWS_DESC","DEFAULT_VALUE":{"TEXT":"","TYPE":"HTML"},"PROPERTY_TYPE":"S","ROW_COUNT":"8","COL_COUNT":"50","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1136","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"Y","FILTRABLE":"Y","VERSION":"2","USER_TYPE":"HTML","IS_REQUIRED":"N","USER_TYPE_SETTINGS":{"height":200},"HINT":"","PROPERTY_VALUE_ID":"1338048:1136","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Анонс для главной новости","~DEFAULT_VALUE":{"TEXT":"","TYPE":"HTML"}},"vote_count":{"ID":"279","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Количество голосов","ACTIVE":"Y","SORT":"15000","CODE":"vote_count","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"279","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:279","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Количество голосов","~DEFAULT_VALUE":""},"vote_sum":{"ID":"280","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Сумма голосов","ACTIVE":"Y","SORT":"15100","CODE":"vote_sum","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"280","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:280","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Сумма голосов","~DEFAULT_VALUE":""},"rating":{"ID":"281","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Рейтинг","ACTIVE":"Y","SORT":"15200","CODE":"rating","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"281","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:281","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Рейтинг","~DEFAULT_VALUE":""},"FORUM_TOPIC_ID":{"ID":"282","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Идентификатор темы форума","ACTIVE":"Y","SORT":"15300","CODE":"FORUM_TOPIC_ID","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"282","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:282","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Идентификатор темы форума","~DEFAULT_VALUE":""},"FORUM_MESSAGE_CNT":{"ID":"283","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Количество комментариев","ACTIVE":"Y","SORT":"15400","CODE":"FORUM_MESSAGE_CNT","DEFAULT_VALUE":"","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"283","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:283","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Количество комментариев","~DEFAULT_VALUE":""},"FILES":{"ID":"1416","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Документы","ACTIVE":"Y","SORT":"15743","CODE":"FILES","DEFAULT_VALUE":"","PROPERTY_TYPE":"F","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"1416","FILE_TYPE":"","MULTIPLE_CNT":"2","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"Y","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":false,"VALUE":false,"DESCRIPTION":false,"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":false,"~DESCRIPTION":false,"~NAME":"Документы","~DEFAULT_VALUE":""},"VIDEO_IMG":{"ID":"1231","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Картинка для ролика","ACTIVE":"Y","SORT":"17761","CODE":"VIDEO_IMG","DEFAULT_VALUE":"","PROPERTY_TYPE":"F","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"1231","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"2","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":false,"VALUE":false,"DESCRIPTION":false,"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":false,"~DESCRIPTION":false,"~NAME":"Картинка для ролика","~DEFAULT_VALUE":""},"VIDEO":{"ID":"1232","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Ролик","ACTIVE":"Y","SORT":"17765","CODE":"VIDEO","DEFAULT_VALUE":null,"PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"1232","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"2","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":"FileMan","IS_REQUIRED":"N","USER_TYPE_SETTINGS":null,"HINT":"","PROPERTY_VALUE_ID":false,"VALUE":false,"DESCRIPTION":false,"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":false,"~DESCRIPTION":false,"~NAME":"Ролик","~DEFAULT_VALUE":null},"AUTO_UP":{"ID":"1490","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Автоматически поднят коэфициент","ACTIVE":"Y","SORT":"50000","CODE":"AUTO_UP","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1490","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1490","VALUE":"","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"","~DESCRIPTION":"","~NAME":"Автоматически поднят коэфициент","~DEFAULT_VALUE":"0"},"FIO":null},"DISPLAY_PROPERTIES":{"FOTO_DESC":{"ID":"1498","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Подпись под фото","ACTIVE":"Y","SORT":"1","CODE":"FOTO_DESC","DEFAULT_VALUE":"Фото rugrad.eu","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1498","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1498","VALUE":"Фото rugrad","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"Фото rugrad","~DESCRIPTION":"","~NAME":"Подпись под фото","~DEFAULT_VALUE":"Фото rugrad.eu","DISPLAY_VALUE":"Фото rugrad"},"CLIPART":{"ID":"1262","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Фото клипарт","ACTIVE":"Y","SORT":"5","CODE":"CLIPART","DEFAULT_VALUE":"N","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1262","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1262","VALUE":"N","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"N","~DESCRIPTION":"","~NAME":"Фото клипарт","~DEFAULT_VALUE":"N","DISPLAY_VALUE":"N"},"DOPINFO":{"ID":"1920","TIMESTAMP_X":"2025-10-31 01:20:12","IBLOCK_ID":"54","NAME":"Допинфо","ACTIVE":"Y","SORT":"500","CODE":"DOPINFO","DEFAULT_VALUE":{"TYPE":"HTML","TEXT":""},"PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":null,"FILE_TYPE":"","MULTIPLE_CNT":"3","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":"HTML","IS_REQUIRED":"N","USER_TYPE_SETTINGS":{"height":200},"HINT":"","PROPERTY_VALUE_ID":["1562204"],"VALUE":[{"TEXT":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u0026lt;a href=\u0026quot;https:\/\/rugrad.online\/news\/1327780\/\u0026quot;\u0026gt;АО «Отисифарм Про\u0026lt;\/a\u0026gt;». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек.","TYPE":"HTML"}],"DESCRIPTION":[null],"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":[{"TEXT":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u003Ca href=\u0022https:\/\/rugrad.online\/news\/1327780\/\u0022\u003EАО «Отисифарм Про\u003C\/a\u003E». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек.","TYPE":"HTML"}],"~DESCRIPTION":[null],"~NAME":"Допинфо","~DEFAULT_VALUE":{"TYPE":"HTML","TEXT":""},"DISPLAY_VALUE":"Сейчас в Калининградской области работает два крупных фармацевтических предприятия: ООО «Инфамед К» и \u003Ca href=\u0022https:\/\/rugrad.online\/news\/1327780\/\u0022\u003EАО «Отисифарм Про\u003C\/a\u003E». Они ведут выпуск безрецептурных лекарственных средств. В общей сложности на производстве лекарственных средств в регионе трудоустроены порядка 900 человек."},"KEYWORDS":{"ID":"274","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Ключевые слова","ACTIVE":"Y","SORT":"500","CODE":"KEYWORDS","DEFAULT_VALUE":"","PROPERTY_TYPE":"S","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"274","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"N","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:274","VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев","~DESCRIPTION":"","~NAME":"Ключевые слова","~DEFAULT_VALUE":"","DISPLAY_VALUE":"лекарства, фармацевтика, препараты, фармпроизводство, калининградская область, андрей горохов, антон бойко, бадма башанкаев"},"NOT_COMMENT":{"ID":"1466","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Запретить комментарии (0 - нет, 1 - да)","ACTIVE":"Y","SORT":"769","CODE":"NOT_COMMENT","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1466","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":"1338048:1466","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Запретить комментарии (0 - нет, 1 - да)","~DEFAULT_VALUE":"0","DISPLAY_VALUE":"0"},"PR":{"ID":"1315","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Рекламная новость (0 - нет, 1 - да, 2 - не эксп., 3 - афиша, 4 - рестораны)","ACTIVE":"Y","SORT":"774","CODE":"PR","DEFAULT_VALUE":"0","PROPERTY_TYPE":"N","ROW_COUNT":"1","COL_COUNT":"2","LIST_TYPE":"L","MULTIPLE":"N","XML_ID":"1315","FILE_TYPE":"","MULTIPLE_CNT":"5","TMP_ID":null,"LINK_IBLOCK_ID":"0","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"Рекламная новость (0 - нет, 1 - да, 2 - не эксп., 3 - афиша, 4 - рестораны)","PROPERTY_VALUE_ID":"1338048:1315","VALUE":"0","DESCRIPTION":"","VALUE_ENUM":"","VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":"0","~DESCRIPTION":"","~NAME":"Рекламная новость (0 - нет, 1 - да, 2 - не эксп., 3 - афиша, 4 - рестораны)","~DEFAULT_VALUE":"0","DISPLAY_VALUE":"0"},"THEMES":{"ID":"278","TIMESTAMP_X":"2025-10-31 01:20:02","IBLOCK_ID":"54","NAME":"Темы","ACTIVE":"Y","SORT":"700","CODE":"THEMES","DEFAULT_VALUE":"","PROPERTY_TYPE":"G","ROW_COUNT":"1","COL_COUNT":"30","LIST_TYPE":"L","MULTIPLE":"Y","XML_ID":"278","FILE_TYPE":"jpg, gif, bmp, png, jpeg","MULTIPLE_CNT":"15","TMP_ID":null,"LINK_IBLOCK_ID":"40","WITH_DESCRIPTION":"N","SEARCHABLE":"N","FILTRABLE":"Y","VERSION":"2","USER_TYPE":null,"IS_REQUIRED":"N","USER_TYPE_SETTINGS":"a:0:{}","HINT":"","PROPERTY_VALUE_ID":["1086887","1086888","1086889"],"VALUE":["1222","1224","1225"],"DESCRIPTION":[null,null,null],"VALUE_ENUM":null,"VALUE_XML_ID":null,"VALUE_SORT":null,"~VALUE":["1222","1224","1225"],"~DESCRIPTION":[null,null,null],"~NAME":"Темы","~DEFAULT_VALUE":"","LINK_SECTION_VALUE":{"1222":{"ID":"1222","~ID":"1222","IBLOCK_ID":"40","~IBLOCK_ID":"40","NAME":"Промышленность и производство ","~NAME":"Промышленность и производство ","SECTION_PAGE_URL":"","~SECTION_PAGE_URL":"","PICTURE":null,"~PICTURE":null,"DETAIL_PICTURE":null,"~DETAIL_PICTURE":null,"SORT":"500","~SORT":"500","CODE":"","~CODE":"","EXTERNAL_ID":"1222","~EXTERNAL_ID":"1222","IBLOCK_TYPE_ID":"services","~IBLOCK_TYPE_ID":"services","IBLOCK_CODE":"themes","~IBLOCK_CODE":"themes","IBLOCK_EXTERNAL_ID":"40","~IBLOCK_EXTERNAL_ID":"40","GLOBAL_ACTIVE":"Y","~GLOBAL_ACTIVE":"Y"},"1224":{"ID":"1224","~ID":"1224","IBLOCK_ID":"40","~IBLOCK_ID":"40","NAME":"Здравоохранение","~NAME":"Здравоохранение","SECTION_PAGE_URL":"","~SECTION_PAGE_URL":"","PICTURE":null,"~PICTURE":null,"DETAIL_PICTURE":null,"~DETAIL_PICTURE":null,"SORT":"500","~SORT":"500","CODE":"","~CODE":"","EXTERNAL_ID":"1224","~EXTERNAL_ID":"1224","IBLOCK_TYPE_ID":"services","~IBLOCK_TYPE_ID":"services","IBLOCK_CODE":"themes","~IBLOCK_CODE":"themes","IBLOCK_EXTERNAL_ID":"40","~IBLOCK_EXTERNAL_ID":"40","GLOBAL_ACTIVE":"Y","~GLOBAL_ACTIVE":"Y"},"1225":{"ID":"1225","~ID":"1225","IBLOCK_ID":"40","~IBLOCK_ID":"40","NAME":"Законодательство ","~NAME":"Законодательство ","SECTION_PAGE_URL":"","~SECTION_PAGE_URL":"","PICTURE":null,"~PICTURE":null,"DETAIL_PICTURE":null,"~DETAIL_PICTURE":null,"SORT":"500","~SORT":"500","CODE":"","~CODE":"","EXTERNAL_ID":"1225","~EXTERNAL_ID":"1225","IBLOCK_TYPE_ID":"services","~IBLOCK_TYPE_ID":"services","IBLOCK_CODE":"themes","~IBLOCK_CODE":"themes","IBLOCK_EXTERNAL_ID":"40","~IBLOCK_EXTERNAL_ID":"40","GLOBAL_ACTIVE":"Y","~GLOBAL_ACTIVE":"Y"}},"DISPLAY_VALUE":["\u003Ca href=\u0022\u0022\u003EПромышленность и производство \u003C\/a\u003E","\u003Ca href=\u0022\u0022\u003EЗдравоохранение\u003C\/a\u003E","\u003Ca href=\u0022\u0022\u003EЗаконодательство \u003C\/a\u003E"]}},"IBLOCK":{"ID":"54","~ID":"54","TIMESTAMP_X":"31.10.2025 01:20:12","~TIMESTAMP_X":"31.10.2025 01:20:12","IBLOCK_TYPE_ID":"news","~IBLOCK_TYPE_ID":"news","LID":"ru","~LID":"ru","CODE":"our_news","~CODE":"our_news","API_CODE":null,"~API_CODE":null,"NAME":"Новости Калининграда","~NAME":"Новости Калининграда","ACTIVE":"Y","~ACTIVE":"Y","SORT":"500","~SORT":"500","LIST_PAGE_URL":"\/news\/","~LIST_PAGE_URL":"\/news\/","DETAIL_PAGE_URL":"http:\/\/rugrad.online\/#SITE_DIR#\/news\/#ID#\/","~DETAIL_PAGE_URL":"http:\/\/rugrad.online\/#SITE_DIR#\/news\/#ID#\/","SECTION_PAGE_URL":"#SITE_DIR#\/news\/#SECTION_code#\/","~SECTION_PAGE_URL":"#SITE_DIR#\/news\/#SECTION_code#\/","PICTURE":"39934","~PICTURE":"39934","DESCRIPTION":"","~DESCRIPTION":"","DESCRIPTION_TYPE":"html","~DESCRIPTION_TYPE":"html","RSS_TTL":"0","~RSS_TTL":"0","RSS_ACTIVE":"N","~RSS_ACTIVE":"N","RSS_FILE_ACTIVE":"N","~RSS_FILE_ACTIVE":"N","RSS_FILE_LIMIT":"50","~RSS_FILE_LIMIT":"50","RSS_FILE_DAYS":"30","~RSS_FILE_DAYS":"30","RSS_YANDEX_ACTIVE":"N","~RSS_YANDEX_ACTIVE":"N","XML_ID":"54","~XML_ID":"54","TMP_ID":"eafb07b19d66a7bd944c6c647edba218","~TMP_ID":"eafb07b19d66a7bd944c6c647edba218","INDEX_ELEMENT":"Y","~INDEX_ELEMENT":"Y","INDEX_SECTION":"Y","~INDEX_SECTION":"Y","VERSION":"2","~VERSION":"2","LAST_CONV_ELEMENT":"0","~LAST_CONV_ELEMENT":"0","EDIT_FILE_BEFORE":"\/bitrix\/php_interface\/include\/iblock\/before_save\/news.php","~EDIT_FILE_BEFORE":"\/bitrix\/php_interface\/include\/iblock\/before_save\/news.php","EDIT_FILE_AFTER":"","~EDIT_FILE_AFTER":"","SECTIONS_NAME":"Группы","~SECTIONS_NAME":"Группы","SECTION_NAME":"Раздел","~SECTION_NAME":"Раздел","ELEMENTS_NAME":"Новость","~ELEMENTS_NAME":"Новость","ELEMENT_NAME":"Элемент","~ELEMENT_NAME":"Элемент","WORKFLOW":"Y","~WORKFLOW":"Y","SECTION_CHOOSER":"L","~SECTION_CHOOSER":"L","BIZPROC":"N","~BIZPROC":"N","LIST_MODE":"","~LIST_MODE":"","SOCNET_GROUP_ID":null,"~SOCNET_GROUP_ID":null,"RIGHTS_MODE":"S","~RIGHTS_MODE":"S","SECTION_PROPERTY":"N","~SECTION_PROPERTY":"N","PROPERTY_INDEX":"N","~PROPERTY_INDEX":"N","CANONICAL_PAGE_URL":"","~CANONICAL_PAGE_URL":"","REST_ON":"N","~REST_ON":"N","EXTERNAL_ID":"54","~EXTERNAL_ID":"54","LANG_DIR":"\/","~LANG_DIR":"\/","SERVER_NAME":"rugrad.online","~SERVER_NAME":"rugrad.online"},"SECTION":{"PATH":[]}}